ReviewFrontiers in oncology2022

Opportunities and challenges of hepatocellular carcinoma organoids for targeted drugs sensitivity screening.

Cuiying Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.